JP Stock MarketDetailed Quotes

4519 Chugai Pharmaceutical

Watchlist
  • 7129.0
  • -187.0-2.56%
20min DelayNot Open Nov 13 15:30 JST
11.97TMarket Cap36.04P/E (Static)

Chugai Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
22.40%315.68B
18.13%315.91B
-24.11%236.95B
-11.78%1.11T
-37.56%273.81B
14.48%257.9B
13.50%267.42B
-13.35%312.24B
26.00%1.26T
36.07%438.5B
Cost of revenue
7.62%84.22B
-4.06%87.94B
-51.79%72.95B
-13.22%413.31B
-56.76%92.06B
13.26%78.26B
14.83%91.66B
32.25%151.33B
40.84%476.25B
92.58%212.91B
Gross profit
28.85%231.46B
29.71%227.97B
1.92%164B
-10.90%698.06B
-19.43%181.75B
15.02%179.64B
12.82%175.76B
-34.57%160.91B
18.42%783.48B
6.55%225.59B
Operating expense
-2.61%71.05B
10.31%69.65B
2.41%64.13B
3.49%258.89B
-20.94%60.18B
23.02%72.96B
13.06%63.14B
6.30%62.62B
4.36%250.17B
4.77%76.11B
Selling and administrative expenses
0.86%27.78B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
-1.89%100.48B
-11.73%30.75B
-Selling and marketing expense
0.86%27.78B
-17.88%27.32B
7.47%22.59B
12.05%112.58B
0.02%30.76B
15.82%27.54B
43.65%33.26B
-7.77%21.02B
31.18%100.48B
26.32%30.75B
Research and development costs
-1.44%44.92B
-3.66%42.94B
-3.53%41.36B
16.87%174.87B
-7.46%41.86B
24.15%45.57B
31.79%44.57B
26.58%42.87B
8.98%149.63B
19.64%45.23B
Other operating expenses
-928.13%-1.65B
95.90%-603M
114.59%185M
-44,726.56%-28.56B
-9,817.97%-12.44B
86.53%-160M
-1,203.82%-14.69B
-156.36%-1.27B
--64M
--128M
Operating profit
50.35%160.41B
40.59%158.32B
1.60%99.87B
-17.65%439.17B
-18.66%121.58B
10.11%106.69B
12.68%112.62B
-47.44%98.3B
26.41%533.31B
7.49%149.47B
Net non-operating interest income (expenses)
-299.24%-1.57B
-65.22%480M
-98.90%15M
51,733.33%4.65B
311.79%1.11B
142.48%788M
78.53%1.38B
-14.63%1.37B
-132.14%-9M
40.30%-526M
Non-operating interest income
---490M
-65.44%480M
-98.90%15M
----
----
----
76.27%1.39B
-15.24%1.37B
----
----
Non-operating interest expense
----
----
----
-55.74%27M
-50.00%8M
-53.33%7M
-40.00%9M
-85.71%2M
27.08%61M
33.33%16M
Total other finance cost
----
----
----
-8,888.46%-4.67B
-320.00%-1.12B
-143.21%-795M
----
----
31.58%-52M
-41.31%510M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)
15.98%-2.13B
3.09%267M
Income before tax
47.79%158.84B
39.31%158.8B
0.23%99.89B
-16.44%443.82B
-17.78%122.69B
13.09%107.48B
13.19%113.99B
-46.48%99.66B
26.65%531.17B
7.78%149.22B
Income tax
65.00%49.34B
52.40%46.94B
-2.57%25.49B
-24.49%118.35B
-32.64%31.48B
9.80%29.9B
8.70%30.8B
-51.94%26.16B
34.67%156.74B
18.03%46.74B
Net income
41.15%109.5B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
Net income continuous operations
41.15%109.5B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
Noncontrolling interests
Net income attributable to the company
41.15%109.5B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
41.15%109.5B
34.46%111.86B
1.23%74.4B
-13.08%325.47B
-11.00%91.21B
14.42%77.57B
14.94%83.19B
-44.22%73.5B
23.58%374.43B
3.68%102.48B
Gross dividend payment
Basic earnings per share
41.15%66.55
34.43%67.98
1.21%45.22
-13.10%197.83
-11.01%55.43
14.41%47.15
14.93%50.57
-44.25%44.68
23.52%227.64
3.61%62.29
Diluted earnings per share
41.13%66.53
34.43%67.97
1.21%45.21
-13.08%197.8
-11.00%55.43
14.42%47.14
14.94%50.56
-44.23%44.67
23.57%227.57
3.66%62.28
Dividend per share
0
2.50%41
0
2.56%80
0.00%40
0
5.26%40
0
2.63%78
-13.04%40
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 22.40%315.68B18.13%315.91B-24.11%236.95B-11.78%1.11T-37.56%273.81B14.48%257.9B13.50%267.42B-13.35%312.24B26.00%1.26T36.07%438.5B
Cost of revenue 7.62%84.22B-4.06%87.94B-51.79%72.95B-13.22%413.31B-56.76%92.06B13.26%78.26B14.83%91.66B32.25%151.33B40.84%476.25B92.58%212.91B
Gross profit 28.85%231.46B29.71%227.97B1.92%164B-10.90%698.06B-19.43%181.75B15.02%179.64B12.82%175.76B-34.57%160.91B18.42%783.48B6.55%225.59B
Operating expense -2.61%71.05B10.31%69.65B2.41%64.13B3.49%258.89B-20.94%60.18B23.02%72.96B13.06%63.14B6.30%62.62B4.36%250.17B4.77%76.11B
Selling and administrative expenses 0.86%27.78B-17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B-1.89%100.48B-11.73%30.75B
-Selling and marketing expense 0.86%27.78B-17.88%27.32B7.47%22.59B12.05%112.58B0.02%30.76B15.82%27.54B43.65%33.26B-7.77%21.02B31.18%100.48B26.32%30.75B
Research and development costs -1.44%44.92B-3.66%42.94B-3.53%41.36B16.87%174.87B-7.46%41.86B24.15%45.57B31.79%44.57B26.58%42.87B8.98%149.63B19.64%45.23B
Other operating expenses -928.13%-1.65B95.90%-603M114.59%185M-44,726.56%-28.56B-9,817.97%-12.44B86.53%-160M-1,203.82%-14.69B-156.36%-1.27B--64M--128M
Operating profit 50.35%160.41B40.59%158.32B1.60%99.87B-17.65%439.17B-18.66%121.58B10.11%106.69B12.68%112.62B-47.44%98.3B26.41%533.31B7.49%149.47B
Net non-operating interest income (expenses) -299.24%-1.57B-65.22%480M-98.90%15M51,733.33%4.65B311.79%1.11B142.48%788M78.53%1.38B-14.63%1.37B-132.14%-9M40.30%-526M
Non-operating interest income ---490M-65.44%480M-98.90%15M------------76.27%1.39B-15.24%1.37B--------
Non-operating interest expense -------------55.74%27M-50.00%8M-53.33%7M-40.00%9M-85.71%2M27.08%61M33.33%16M
Total other finance cost -------------8,888.46%-4.67B-320.00%-1.12B-143.21%-795M--------31.58%-52M-41.31%510M
Net investment income
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses) 15.98%-2.13B3.09%267M
Income before tax 47.79%158.84B39.31%158.8B0.23%99.89B-16.44%443.82B-17.78%122.69B13.09%107.48B13.19%113.99B-46.48%99.66B26.65%531.17B7.78%149.22B
Income tax 65.00%49.34B52.40%46.94B-2.57%25.49B-24.49%118.35B-32.64%31.48B9.80%29.9B8.70%30.8B-51.94%26.16B34.67%156.74B18.03%46.74B
Net income 41.15%109.5B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B
Net income continuous operations 41.15%109.5B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B
Noncontrolling interests
Net income attributable to the company 41.15%109.5B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 41.15%109.5B34.46%111.86B1.23%74.4B-13.08%325.47B-11.00%91.21B14.42%77.57B14.94%83.19B-44.22%73.5B23.58%374.43B3.68%102.48B
Gross dividend payment
Basic earnings per share 41.15%66.5534.43%67.981.21%45.22-13.10%197.83-11.01%55.4314.41%47.1514.93%50.57-44.25%44.6823.52%227.643.61%62.29
Diluted earnings per share 41.13%66.5334.43%67.971.21%45.21-13.08%197.8-11.00%55.4314.42%47.1414.94%50.56-44.23%44.6723.57%227.573.66%62.28
Dividend per share 02.50%4102.56%800.00%4005.26%4002.63%78-13.04%40
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data